Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2025-10-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
第十届监事会第十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is an announcement of the supervisory board meeting resolution approving the company's 2025 third quarter report. It states that the supervisory board reviewed and approved the 2025 third quarter report and confirms its accuracy and compliance. However, the document itself does not contain the full quarterly report or detailed financial data; it refers readers to the full report disclosed elsewhere (on the Juchao Information Network). The document length is short (681 characters) and serves as a formal announcement of the meeting resolution and approval of the quarterly report, not the report itself. According to the 'Menu vs Meal' rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a regulatory announcement related to the quarterly report approval but does not contain the substantive financial report data itself.
2025-10-30 Chinese
关于2025年前三季度计提资产减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by the company about the asset impairment provision for the first three quarters of 2025. It details the amount of impairment, the accounting standards applied, and the impact on profits. The document is relatively short (1586 characters) and focuses on a specific accounting adjustment rather than providing a full financial report or comprehensive quarterly results. It does not contain full financial statements or detailed financial analysis typical of an Interim/Quarterly Report (IR). Instead, it is a regulatory announcement about a specific accounting provision. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such announcements that do not fit other specific report types.
2025-10-30 Chinese
关于全资子公司调整产业园租赁事项的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the adjustment of leasing matters for a subsidiary's industrial park. It details contractual changes, parties involved, rental terms, and the impact on the company. There are no financial statements, earnings data, or detailed financial analysis present. The document is a formal public announcement about a business transaction related to leasing, not a financial report or regulatory certification. It is also not a report publication announcement since it contains substantive details about the leasing adjustment itself. Therefore, the document fits best under the category of Capital/Financing Update (CAP), as it relates to changes in the company's capital use or asset leasing arrangements.
2025-10-30 Chinese
2025年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "成都市贝瑞和康基因技术股份有限公司2025 年第三季度报告" which translates to "Chengdu Berry Genomics Co., Ltd. 2025 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and shareholder information for the third quarter of 2025. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period. It also mentions that the report is unaudited, which is common for interim or quarterly reports. The length of the document (13,085 characters) and the detailed financial content confirm it is the actual report, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2025
2025-10-30 Chinese
关于为全资子公司的借款提供反担保的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a listed company regarding providing a counter-guarantee for a loan taken by its wholly-owned subsidiary. It details the board meeting resolutions, the parties involved, the guarantee amounts, and compliance with regulatory requirements. The document is a formal disclosure about a financing-related guarantee arrangement, not a financial report, earnings release, or management discussion. It is not a full report but an announcement of a corporate action related to financing and guarantees. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 1762 characters, which is consistent with an announcement rather than a full report.
2025-10-30 Chinese
第十届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 18th meeting of the 10th Board of Directors of the company. It includes voting results on various agenda items such as approval of the 2025 Q3 report, adjustments in subsidiary leasing, guarantees for subsidiary loans, and changes in securities affairs representatives. The document does not contain the full quarterly report or detailed financial data but refers to the full 2025 Q3 report being disclosed elsewhere. The document is primarily about board meeting decisions and voting outcomes, not the report itself. Therefore, it fits best under Board/Management Information (MANG).
2025-10-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.